Efficacy and Safety of Pembrolizumab in Previously Treated Advanced Cervical Cancer: Results From the Phase II KEYNOTE-158 Study

Hyun Cheol Chung, Willeke Ros, Jean‐Pierre Delord, +9

Journal of Clinical Oncology

Transformation of the Fallopian Tube Secretory Epithelium Leads to High-Grade Serous Ovarian Cancer in Brca;Tp53;Pten Models

Ruth Perets, Gregory A. Wyant, Katherine W. Muto, +13

Cancer Cell

Proteomics reveals NNMT as a master metabolic regulator of cancer-associated fibroblasts

Mark A. Eckert, Fabian Coscia, Agnieszka Chryplewicz, +17

Nature

Tumor BiologyMaster Metabolic RegulatorMedicineCancer-associated FibroblastsTumor Suppressor +6

A Comprehensive Analysis of PAX8 Expression in Human Epithelial Tumors

Anna Laury, Ruth Perets, Huiying Piao, +9

The American Journal of Surgical Pathology

Tumor BiologyThyroid TumorsOncologyPax8 SpecificityGenitourinary Cancer +11

PAX8 Reliably Distinguishes Ovarian Serous Tumors From Malignant Mesothelioma

Anna Laury, Jason L. Hornick, Ruth Perets, +4

The American Journal of Surgical Pathology

Transcription Factor Pax8Tumoral PathologySurgical PathologyGynecologyPathology +8

Mouse Ovarian Cancer Models Recapitulate the Human Tumor Microenvironment and Patient Response to Treatment

Eleni Maniati, Chiara Berlato, Ganga Gopinathan, +15

Cell Reports

Pembrolizumab treatment of advanced cervical cancer: Updated results from the phase 2 KEYNOTE-158 study.

Hyun Cheol Chung, Jan H.M. Schellens, Jean‐Pierre Delord, +9

Journal of Clinical Oncology

ImmunologyGynecologyPathologyGynecology OncologyOncology +18

PRKCI promotes immune suppression in ovarian cancer

Sharmistha Sarkar, Christopher A. Bristow, Prasenjit Dey, +19

Genes & Development

Mutant <i>KRAS</i> Circulating Tumor DNA Is an Accurate Tool for Pancreatic Cancer Monitoring

Ruth Perets, Orli Greenberg, Talia Shentzer, +7

The Oncologist

Safety and efficacy of quavonlimab, a novel anti-CTLA-4 antibody (MK-1308), in combination with pembrolizumab in first-line advanced non-small-cell lung cancer

Ruth Perets, Jair Bar, Drew Rasco, +17

Annals of Oncology